Biotechnology Archives - Page 7 of 32

BCRX Stock Soars After Filing Treatment for Japanese Approval

BCRX stock is soaring today after BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it had filed for regulatory approval in Japan for Berotralstat, a prophylactic treatment of hereditary angioedema (HAE). BioCryst has already received Orphan Drug and ... [Read]

HEPA Stock Rockets 33% on Positive NASH Treatment Data

Jan 29 Ankit Singhania

In the world of pharmaceutical stocks, positive data for medicine in the pipeline leads to a spike in the company’s stock price on most occasions, and that is what happened with the HEPA stock on ... [Read]

GNPX Stock Quadruples on FDA Fast Track Status for Oncoprex Therapy

Jan 21 Ankit Singhania

In a new development that has come as a significant boost for GNPX stock, Genprex Inc (NASDAQ:GNPX) today announced that one of its products has been awarded a fast track designation by the United States ... [Read]

NVAX Stock Soars 44% in a Week on Bullish Sentiment

Jan 20 Ankit Singhania

When a pharmaceutical or biotech company manages to get a highly positive update with regards to one of its products in development, then the stock price generally moves in the right direction. That is what ... [Read]

CLVS Stock Rockets 20% as FDA Grants Priority Review to Rubraca

Jan 15 Ankit Singhania

CLVS stock is trading sharply higher this morning after the FDA has accepted Clovis Oncology’s (NASDAQ:CLVS) supplemental marketing application seeking approval to use Rubraca (rucaparib). Major News In a new development that has come as ... [Read]

DARE Stock Soars 125% on Licensing Deal with Bayer

Jan 13 Ankit Singhania

When a relatively small company signs a significant deal with one of the biggest companies in the world, then the former’s stock generally soars substantially. That is what happened with DARE stock this morning after ... [Read]

PHAS Stock Rockets 25% on Collaboration With SFJ Pharma

Jan 10 Ankit Singhania

In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that ... [Read]

XERS Stock Jumps 12% Following Positive RTU Glucagon Data

Jan 7 Ankit Singhania

When a pharmaceutical company announces positive results from any stage of a clinical study, then it almost always has a positive effect on the company’s stock. That is what happened with XERS stock in the ... [Read]

LPTX Stock Soars 60% After a Licensing Deal With BeiGene

Jan 3 Ankit Singhania

Licensing agreements are generally great news for pharmaceutical companies, which is why such a development almost always proves to be a positive for the stock price. That is what happened with LPTX stock this morning ... [Read]

PULM Stock Skyrockets 86% on Licensing Deal With Johnson & Johnson

Jan 2 Ankit Singhania

When a relatively small company ends up striking a deal with a giant corporation, then it generally proves to be a major boost for the stock. That is what has happened this morning with lightly ... [Read]